Pharmaleaders
2014 Leadership Summit to debate “Make In India” & Healthcare Reforms!
Decision-makers,
Opinion Leaders & Pharmaleaders to meet to discuss consequences of actions
and of non-actions to accelerate Healthcare Reforms at 7th Annual
Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards
2014
Monday,
26th October 2014, Mumbai, Maharashtra: At
a time when the new government at the centre led by BJP led Modi
Government is busy trying to repair
existing potholes, fix areas of concerns , repeal unnecessary & cumbersome
laws to bring meaningful reforms to infuse confidence & trust in the minds
of the investors, all is not well in the pharmaceutical & healthcare
sector. While the previous & predecessor regimes repeatedly failed to
effect a new change of policy to bring far reaching changes in the highly
sensitive & knowledge based industry, the present regime will have to work
hard to make India preferred destination of investments in medical devices,
pharmaceutical manufacturing & healthcare innovations. Keeping the mantra
of “Make In India” campaign,
Pharmaleaders ( www.pharmaleaders.tv ), India’s most
analytical news media in healthcare communications is hosting the much awaited
& widely acclaimed annual event, the 7th Annual Pharmaceutical
Leadership Summit & Pharmaleaders Business Leadership Awards 2014( www.pharmaleaders2014.in ) in a uniquely positioned full day program
encompassing two themes “Make In India –
Healthcare Reforms , Insurance,Innovations,Investments & Infrastructure”
& Empowering India’s Developing Healthcare System - Investing the Healthcare
Solutions of Tomorrow in difficult Times at on December. 26, 2014 at the
Sahara Star, Mumbai International Airport in Mumbai, India.
Pharmaleaders believe that
much need to be done to accomplish the super success in the pharmaceutical
industry & a series of steps need to be initiated to expel the confusion
that prevail amongst the investors & manufacturers. Industry experts
believe that Prime Minister Modi has the oppourtunity to turn the table forward
& make india proud as she says “Make
in India” is a great slogan but can we back it with enabling
policies?Manufacturing calls for low cost capital, speed of project
implementation, operational efficiency and global competitiveness. Prime
Minister Modi’s 3D campaign for Democracy, Demography and Demand revolves
around the principles of free enterprise, demographic dividend and market
demand. However, in reality, none of these are easy to achieve in India. Over
regulation and nepotism have crippled free enterprise, poor education has
resulted in a skill deficit and sub-optimal logistics and inadequate
infrastructure has stifled demand. We have to add to this the cumbersome and
difficult land acquisition and labour laws that challenge the credibility of
“Make in India”. A “Made in India” label has a huge credibility challenge in
terms of quality, consistency and dependability. We need urgent regulatory and
policy reforms that are aligned with what “Make in India” should stand for:
Highest Quality at Lowest Cost. A combination of self-certification and third party
audits can provide a quick start to address speed and quality. Special Economic
Zones (SEZs) need to be revived and revitalized as they are neither “Special”
nor “Economic”! We have 478 approved SEZs of which only 172 are operational.
Simplification of operational norms through self-certification, removal of the
Minimum Alternate Tax (MAT) and Dividend Distribution Tax (DDT) and perhaps
exempting Domestic Tariff Area (DTA) sales from duties will energize this
ailing sector. It is worth noting that the 172 SEZs that are operational,
account for 25% of manufacturing exports.
If India is to build a
credible scientific and engineering profile, then we do need to seriously
invest in research in the public and private sectors. India’s Space Research
budget was a modest $1.3 Billion for FY15 compared to NASA’s $16.6 Billion.
Despite this frugal investment, ISRO has had a number of successful space
programs crowned by the Mars Orbiter Mission. Behind its success is a vibrant
multi-disciplinary scientific and engineering talent pool. Mangalyaan is a
powerful mascot for Indian Science and Technology. Scaling up ISRO will provide
exciting opportunities to Physicists, Mathematicians, Computer Scientists,
Engineers and even Life Scientists which in turn will create a virtuous cycle
for young minds to pursue science. India needs scale and ambition in its
scientific and technological endeavours if our science-led national narrative
is to be credible. We need to establish large scientific centres of excellence
across the Physical and Life Sciences, Mathematics and Computational sciences.
Big Data Analytics is ours for the taking but we need to commit to global
leadership by investing significantly in this sector. Genomics, for example, is
an area where we can excel and leverage big data analytics and yet we do not
have any Genomics Institute of any credible scale.
Drug discovery has always
been an area that has eluded us despite our scientific and medical talent pool.
We have preferred to export our talent than provide them with a research
platform in our country. Our doctors have preferred to be medical practitioners
than clinical researchers. Our pharmaceutical companies have preferred to
imitate and produce generic drugs rather than innovate and develop novel drugs.
All this has led to a risk-averse eco-system in bio-medical research which has
seen a ban on clinical trials, a hesitant regulatory system that does not have
confidence in approving new drugs and above all, a medical community who trust
foreign rather than home grown innovation. Moreover, we have barely created any
Intellectual Property that could add credible value to our scientific pursuits.
Unless we change this, we will not leverage the rich talent pool that we have
and we will lose an opportunity to lead in an area so critical to our people
who deserve access to affordable and innovative therapeutics.
Pharmaleaders attempt
is to recognize and celebrate science
and innovation in the pharmaceutical, biotechnology, lifescience &
healthcare industry. At the celebration day of the Awards, Companies,
Academics, Partners, Government and Delegates get a glimpse of Pharmaleaders’s
ongoing research and a walk through of the Network 7 Media Group ’s most recent
innovations in the complex field of understanding & analyzing genes of the
healthcare industry as Pharmaleaders feel that “no one understands the returning
the smiles to the achievers they deserve most”.
Pharmaleaders Business Leadership Awards and the ceremony at which
they are presented have become an industry tradition. This year’s award
recipients will receive their awards during the 7th Annual Pharmaceutical
Leadership Summit & Pharmaleaders Business Leadership Awards 2014 at the 2014 “Empowering India’s Developing
Healthcare System “Summit on December. 26, 2014 at the Sahara Star, Mumbai
International Airport in Mumbai, India in a glittering award Night.
"Pharmaleaders Power
Brand Awards are the most prestigious annual industry awards recognized
annually that acknowledge and honor individuals and organizations for their
accomplishments using healthcare innovations
to deliver the best value in achieving specific goals and
objectives," said Satya Brahma,
Chairman & Editor-In-Chief of Network 7 Media Group . These are fitting tribute to those individuals and companies that have
gone the extra mile to advance the excellence in healthcare through best practices and leadership.
Pharmaleaders Business
Leadership Awards, the largest business and technology leadership awards
program in the Pharmaceutical industry, cover 30 categories spanning from
biotech to Healthcare to CEO awards.
“Regarding the 2014, the 7th
Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership
Awards 2014, we have been honoring
outstanding scientific contributions for more than a decade and are
privileged to recognize the work of accomplished leaders “As a true friend,
philosopher & guide, we are deeply committed to creating a more sustainable
future through scientific research and we will continue to support visionary
pharma leaders as they strive to advance
our understanding in all fields of the pharmaceutical & healthcare
industry. “The Pharmaceutical Leadership & Pharmaleaders Business
Leadership Awards” was first bestowed in
India in 19991 In order to reflect the increasingly global nature of the
awards, it was then revaluated & reshaped in more credible formats in the
year 2008 & since than these awards serve as a benchmark of innovation.
Over the last one decade,
since the institutionalization of recognizing excellence in healthcare &
pharmaceutical business in the form of Pharmaleaders Business Leadership Awards
, Pharmaleaders has recognized several individuals and organizations that have
empowered the healthcare industry in the global map by creating values &
manufacturing prowess;. These Pharmaleaders and organizations inspire the
public by motivating others to carry out their calls to action, by serving as a
champion for their cause and by demonstrating a clear record of accomplishment
in addressing urgent, relevant and complex healthcare needs , problems &
solutions. They also maintain consistent, long-lasting relationships with the
people and communities in which they work.They are truly trendsetters. Thus the
Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership
Awards conducted years after years are truly India’s only dedicated celebration
of excellence in healthcare innovation, pharmaceutical & medical excellence
and brand transformation.Most eagerly awaited annual affair in india, these set
of awards reflect benchmark of credibility, leadership spirit & regarded by
the industry experts as “Pharmaleaders Power Brands”.
Network 7 Media Group will
continue its tradition of recognizing those in the healthcare space whose work
truly creates positive change & this years awards will highlight the
magnificent delivery of work of the
Leaders who not only illustrates the Summit’s mission of Healthcare
empowerment, but also embodies the idea of “The Power of Indians’.
As one of the recently
industrialized nations, India has a fast-growing economy as well as an
ever-expanding, ever-urbanized population, however its healthcare system still
has a lot of potential for development. To Western readers, analyzing a
healthcare system in the East seems daunting. It takes some of us decades to
master an understanding of the healthcare system of our origin country.
Nevertheless, there are several methods to approaching another country’s
system. These include the exposition of some invariant principles that apply
across various contexts, the application of existing frameworks for healthcare
system analysis, appraisal of the major transitions underway in the country,
and an analysis of the country’s public health issues.
India faces challenges in
pursuing each of these goals. With regards to cost, at least 70% of all
healthcare is frequently financed out-of-pocket by the population. There is
little health insurance or other forms of risk pooling, little regulation and
accountability of providers, and a predominance of fee-for-service payment, all
of which are associated with high costs. There is also questionable efficiency
of much of the state healthcare system, and a great distrust of the public
sector.
Against the backdrop of the
above challenges, Pharmaleaders has lined up top industry experts, Pharma
Academia, Ministry Officials, Government Representative, Policy Makers &
Medical Professionals under one platform both in india & abroad to debate
& deliberate the complex issues of the industry & give a meaningful
discussion on the Brand India & Make In India concept. More than 300
professionals will be participating the mega event where professionals from
Middle East, Africa, Europe, Lation America will also be attending.
Media
Contacts
Debashish
Mishra
Plot
5, NS Road No. 12, (Opposite Crepe station),
JVPD,
Juhu Scheme,Mumbai,
Maharashtra,
Pin 400049
T:+91
22 43 000 999
F:
+91 22 43 000 909
M
: 91 22 7411003233
[email protected]
Web
: www.pharmaleaders2014.in